SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-20-001135
Filing Date
2020-01-15
Accepted
2020-01-15 17:30:19
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12020_aditxtherapeutics.htm S-1 1106139
2 CONSENT OF DBBMCKENNON fs12020ex23-1_aditxtherap.htm EX-23.1 2370
3 CONSENT OF NAMVAR KIAIE TO BE NAMED AS A DIRECTOR UPON COMPLETION OF THE OFFERIN fs12020ex99-1_aditxtherap.htm EX-99.1 2201
4 CONSENT OF LAURA ANTHONY TO BE NAMED AS A DIRECTOR UPON COMPLETION OF THE OFFERI fs12020ex99-2_aditxtherap.htm EX-99.2 2204
5 GRAPHIC image_001.jpg GRAPHIC 6917
6 GRAPHIC image_002.jpg GRAPHIC 60022
7 GRAPHIC image_003.jpg GRAPHIC 94687
8 GRAPHIC image_004.jpg GRAPHIC 74524
  Complete submission text file 0001213900-20-001135.txt   1439714
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-235933 | Film No.: 20528955
SIC: 2834 Pharmaceutical Preparations